Overview
Indications
Micafungin for injection is indicated for: Limitations of Use • Candida 14.1 8.4 [see Clinical Studies () and Use in Specific Populations ()] Treatment of Candidemia, Acute Disseminated Candidiasis,Peritonitis and Abscesses in adult and pediatric patients 4 months of age and older • Candida without 8.4 [see Use in Specific Populations ()] Treatment of Candidemia, Acute Disseminated Candidiasis,Peritonitis and Abscessesmeningoencephalitis and/or ocular dissemination in pediatric patients younger
Contraindications
When this intervention should not be used
Micafungin for injection is contraindicated in persons with known hypersensitivity to micafungin, any component of micafungin for injection, or other echinocandins.
Indications & Related Conditions
Conditions associated via SNOMED clinical relationships
Administration & Protocol
Dosing, route, and treatment protocol
Detailed dosage and administration information is available in the full FDA drug label.
View full prescribing information on DailyMedMonitoring & Follow-Up
Biomarkers relevant to this intervention via related conditions
No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.
Clinical Trials
9 trials linked to this intervention
Recent Trials
Pharmacokinetic Study on Echinocandins for Patients With Septic Shock Following Secondary Peritonitis (EPI Study)
Pharmacokinetics of Micafungin in Patients of Intensive Care Units
Micafungin Versus Amphotercine B in Treatment of Invasive Fungal Infection
Comparison of Candida Eradication and Serum Cidal Activity of Echinocandins
Evaluate Bioequivalence of Micafungin (50mg/Vial)
Research Evidence
Published studies and systematic reviews
Research data from MEDLINE/PubMed
Benefits & Expected Outcomes
Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.
Risks & Side Effects
Adverse reaction and safety data for this drug is sourced from the FDA-approved label.
View adverse reactions & drug interactions on DailyMedRelated Symptoms
Symptoms associated with conditions this intervention addresses
No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.
Alternatives & Comparisons
Alternative treatments, comparison data, and clinical decision support are pending physician authorship.
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Do not start, stop, or change any treatment without consulting your healthcare provider.
Quick Facts
- Type
- Substance / Medication
- Fully Specified Name
- Micafungin (substance)
- SNOMED CT
- 416127003
- UMLS CUI
- C1120386
- RxNorm CUI
- 325887
- Labeler
- Glenmark Pharmaceuticals Inc., USA
Clinical Data
This intervention maps to 2 entities in the Ltrl knowledge graph.
Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.